Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine clinical programs — 308 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
442
Patents
706
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Disc Medicine projects

308 ClinicalTrials.gov programs sponsored by Disc Medicine.

Disc Medicine has 308 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

308 programs

Clinical programs

Page 3 of 7

  1. Cisplatin Accord Healthcare /ml concentraat v... for Vulvar cancer

    Disc Medicine

    Vulvar cancer

    phase 2 small molecule active

    1 trial

  2. DABRAFENIB , TRAMETINIB

    Disc Medicine

    ANAPLASTIC THYROID CANCER

    phase 2 small molecule active

    1 trial

  3. DAROTAXEL

    Disc Medicine

    metastatic castration-resistant prostate cancer

    phase 2 small molecule active

    1 trial

  4. DEFEROXAMINE , GALLIUM (68GA) CHLORIDE

    Disc Medicine

    Pulmonary aspergillosis

    phase 2 small molecule active

    1 trial

  5. DISC-0974

    Disc Medicine

    Myelofibrosis; Anemia

    phase 2 small molecule active

    1 trial

  6. DISC-0974

    Disc Medicine

    Inflammatory Bowel Disease (IBD)

    phase 2 small molecule active

    1 trial

  7. DISC-3405

    Disc Medicine

    Polycythemia Vera (PV)

    phase 2 small molecule active

    1 trial

  8. Durability of protection after single immunis... for Falciparum malaria

    Disc Medicine

    Falciparum malaria

    phase 2 other active

    1 trial

  9. ESR-17-13082

    Disc Medicine

    Locally advanced rectal cancer

    phase 2 small molecule active

    1 trial

  10. ESR-21-21284

    Disc Medicine

    Sjogren's disease

    phase 2 small molecule active

    1 trial

  11. EUCT 2024-511805-42

    Disc Medicine

    Cardiogenic shock

    phase 2 small molecule active

    1 trial

  12. EXENATIDE

    Disc Medicine

    paragangliomas

    phase 2 small molecule active

    1 trial

  13. EXENATIDE

    Disc Medicine

    Gestational diabetes

    phase 2 small molecule active

    1 trial

  14. EXENATIDE , VERAPAMIL

    Disc Medicine

    type 1 diabetes mellitus

    phase 2 small molecule active

    1 trial

  15. Embrace-III Hi-Risk

    Disc Medicine

    high risk or poor response after chemoradiation and brachytherapy for locally advanced cervix cancer

    phase 2 small molecule active

    1 trial

  16. Erbitux 5 mg/mL solution for infusion

    Disc Medicine

    Unknown primary tumour of the head and neck

    phase 2 small molecule active

    1 trial

  17. GEM 2301

    Disc Medicine

    Melanoma

    phase 2 small molecule active

    1 trial

  18. GEM 2303

    Disc Medicine

    Advanced Melanoma

    phase 2 small molecule active

    1 trial

  19. GEM-2101

    Disc Medicine

    Uveal melanoma

    phase 2 small molecule active

    1 trial

  20. GEMCAD - 2103//MO4

    Disc Medicine

    Squamous cell carcinoma of the anal canal

    phase 2 small molecule active

    1 trial

  21. GEMCAD 2102

    Disc Medicine

    Colorectal cancer

    phase 2 small molecule active

    1 trial

  22. GEMCAD-1802

    Disc Medicine

    Colorectal cancer and metastatic disease limited to the liver with bad prognosis.

    phase 2 small molecule active

    1 trial

  23. Gamma-retroviral vector MP71 MC2 TCR16-3D9

    Disc Medicine

    advanced melanoma or HNSCC

    phase 2 small molecule active

    1 trial

  24. Gazyvaro 1 for Sjögren's syndrome

    Disc Medicine

    Sjögren's syndrome

    phase 2 small molecule active

    1 trial

  25. Giapreza 2.5 mg/ml concentrate for solution for infusion

    Disc Medicine

    Liver cancer (primary or secondary)

    phase 2 small molecule active

    1 trial

  26. HO161

    Disc Medicine

    relapsed/refractory Non-Hodgkin Lymphoma

    phase 2 small molecule active

    1 trial

  27. Humira 40 mg solution for injection in pre-filled syringe

    Disc Medicine

    Inflammatory Bowel Disease (IBD)

    phase 2 small molecule active

    1 trial

  28. IDP-121 Concentrate for solution for infusion 3 mg/mL

    Disc Medicine

    Unresectable/metastatic Small cell Lung Cancer (SCLC)

    phase 2 small molecule active

    1 trial

  29. IDP-121 Concentrate for solution for infusion 3 mg/mL

    Disc Medicine

    Chronic lymphocytic leukemia (CLL), Any type of B-cell lymphomas, Multiple myeloma (MM)

    phase 2 small molecule active

    1 trial

  30. IL-6 aGVHD Siltuximab: A phase II study to as...

    Disc Medicine

    Grade III/IV acute graft versus host disease of the liver of/and the gastro-intestinal tract

    phase 2 other active

    1 trial

  31. IMCIVREE 10 mg/ml solution for injection

    Disc Medicine

    ROHHAD syndrome

    phase 2 small molecule active

    1 trial

  32. IMFINZI for Metastatic pancreatic cancer

    Disc Medicine

    Metastatic pancreatic cancer

    phase 2 small molecule active

    1 trial

  33. IPILIMUMAB for metastasized melonama uveal

    Disc Medicine

    metastasized melonama uveal

    phase 2 small molecule active

    1 trial

  34. ITCC-054/AAML1921

    Disc Medicine

    Chronic Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  35. Idefirix 11 mg powder for concentrate for solution for infusion

    Disc Medicine

    neuromyelitis optica spectrum disorder, devic disease

    phase 2 small molecule active

    1 trial

  36. Induction of neo-antigen specific T cells by... for Ovarian cancer

    Disc Medicine

    Ovarian cancer

    phase 2 other active

    1 trial

  37. Irinotecan Accord 20 mg/ml concentraat voor oplossing voor infusie

    Disc Medicine

    Gastric peritoneal metastases

    phase 2 small molecule active

    1 trial

  38. KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Disc Medicine

    Mismatch repair deficient endometrial cancer / uterine cancer

    phase 2 small molecule active

    1 trial

  39. KEYTRUDA 25 mg/mL concentrate for solution for infusion

    Disc Medicine

    Vulvar squamous cell carcinoma

    phase 2 small molecule active

    1 trial

  40. KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion

    Disc Medicine

    Metastatic uveal melanoma with resectable liver metastasis and absence of extra-liver disease

    phase 2 small molecule active

    1 trial

  41. Late immunity following single immunization with GA2 sporozoites (GACHA)

    Disc Medicine

    Falciparum malaria

    phase 2 other active

    1 trial

  42. Leflunomide CF for primary Sjögren's Syndrome

    Disc Medicine

    primary Sjögren's Syndrome

    phase 2 small molecule active

    1 trial

  43. Lysergide D-tartrate for Chronic cluster headache

    Disc Medicine

    Chronic cluster headache

    phase 2 small molecule active

    1 trial

  44. Mekinist 0.5 mg film-coated tablets

    Disc Medicine

    Neurofibromatosis type 1

    phase 2 small molecule active

    1 trial

  45. Mektovi film-coated tablets for metastatic colorectal cancer wi…

    Disc Medicine

    metastatic colorectal cancer with a proven RAS mutation after failure of standard systemic treatment regimens including at least 5- FU/capecitabine-oxaliplatin and irinotecan based standard treatment (unless contra-indications for either oxaliplatin or irinotecan)

    phase 2 small molecule active

    1 trial

  46. Mesenchymal stem cells for Systemic Sclerosis

    Disc Medicine

    Systemic Sclerosis

    phase 2 small molecule active

    1 trial

  47. Mineral-enriched powder

    Disc Medicine

    Iron Deficiency

    phase 2 other completed

    1 trial

  48. NIVOLUMAB

    Disc Medicine

    Peritoneal Mesothelioma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Disc Medicine have?

308 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.